These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview. Frick VO; Rubie C; Keilholz U; Ghadjar P World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629 [TBL] [Abstract][Full Text] [Related]
4. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Rubie C; Oliveira V; Kempf K; Wagner M; Tilton B; Rau B; Kruse B; Konig J; Schilling M Tumour Biol; 2006; 27(3):166-74. PubMed ID: 16641550 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062 [TBL] [Abstract][Full Text] [Related]
6. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin. Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114 [TBL] [Abstract][Full Text] [Related]
8. Feasibility and short-term outcome of adjuvant FOLFOX after resection of colorectal liver metastases. Sakamoto Y; Beppu T; Miyamoto Y; Okabe H; Ida S; Imai K; Chikamoto A; Watanabe M; Takamori H; Baba H J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):307-12. PubMed ID: 22610308 [TBL] [Abstract][Full Text] [Related]
9. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Ghadjar P; Rubie C; Aebersold DM; Keilholz U Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006 [TBL] [Abstract][Full Text] [Related]
10. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment. Zhao S; Mi Y; Zheng B; Wei P; Gu Y; Zhang Z; Xu Y; Cai S; Li X; Li D J Extracell Vesicles; 2022 Jan; 11(1):e12186. PubMed ID: 35041299 [TBL] [Abstract][Full Text] [Related]
11. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients. Komori H; Beppu T; Baba Y; Horino K; Imsung C; Masuda T; Hayashi H; Okabe H; Ootao R; Watanabe M; Takamori H; Iyama K; Baba H Int J Clin Oncol; 2010 Jun; 15(3):263-70. PubMed ID: 20238233 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer. Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098 [TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078 [TBL] [Abstract][Full Text] [Related]
14. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway. Guo W; Li H; Liu H; Ma X; Yang S; Wang Z Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256 [TBL] [Abstract][Full Text] [Related]
15. [Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis]. Amano R; Yamada N; Noda E; Kubo N; Tanaka H; Muguruma K; Inoue T; Yashiro M; Maeda K; Onoda N; Sawada T; Nakata B; Ohira M; Ishikawa T; Hirakawa K Gan To Kagaku Ryoho; 2009 Nov; 36(12):2003-5. PubMed ID: 20037305 [TBL] [Abstract][Full Text] [Related]
16. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer. Umehara M; Umehara Y; Takahashi K; Murata A; Nishikawa S; Tokura T; Matsuzaka M; Tanaka R; Morita T Anticancer Res; 2016 Apr; 36(4):1949-54. PubMed ID: 27069185 [TBL] [Abstract][Full Text] [Related]
17. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma. Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888 [TBL] [Abstract][Full Text] [Related]
18. Metastatic colorectal cancer with severe liver dysfunction successfully treated using FOLFOX therapy. Shimura T; Kataoka H; Hirata Y; Mizushima T; Murakami K; Mabuchi M; Mizoshita T; Kubota E; Tanida S; Kamiya T; Joh T J Gastrointest Cancer; 2011 Mar; 42(1):68-72. PubMed ID: 20563895 [TBL] [Abstract][Full Text] [Related]
19. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620 [TBL] [Abstract][Full Text] [Related]